Found 1 results
Filters: Author is F.S.N. Lizarte  [Clear All Filters]
D. F. Barione, Lizarte, F. S. N., Novais, P. C., de Carvalho, C. A. M., Valeri, F. C. B., Peria, F. M., de Oliveira, H. F., Zanette, D. L., Silva, Jr., W. A., Cologna, A. J., Reis, R. B., Tucci, Jr., S., Martins, A. C. P., Tirapelli, D. P. C., and Tirapelli, L. F., Gene expression study related with the intrinsic pathway of apoptosis in bladder cancer by real-time PCR technique, vol. 12, pp. 878-886, 2013.
Ameisen JC (2002). On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 9: 367-393. PMid:11965491   Ashkenazi A and Dixit VM (1998). Death receptors: signaling and modulation. Science 281: 1305-1308. PMid:9721089   Bilim VN, Tomita Y, Kawasaki T, Takeda M, et al. (1998). Variable Bcl-2 phenotype in benign and malignant lesions of urothelium. Cancer Lett. 128: 87-92.   Bilim V, Kasahara T, Hara N, Takahashi K, et al. (2003). Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int. J. Cancer 103: 29-37. PMid:12455050   Budihardjo I, Oliver H, Lutter M, Luo X, et al. (1999). Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15: 269-290. PMid:10611963   Christoph F, Hinz S, Kempkensteffen C, Weikert S, et al. (2007). A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer. J. Cancer Res. Clin. Oncol. 133: 343-349. PMid:17160380   Christoph F, Hinz S, Weikert S, Kempkensteffen C, et al. (2008). Comparative promoter methylation analysis of p53 target genes in urogenital cancers. Urol. Int. 80: 398-404. PMid:18587251   Cory S and Adams JM (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2: 647-656. PMid:12209154   Deveraux QL and Reed JC (1999). IAP family proteins - suppressors of apoptosis. Genes Dev. 13: 239-252. PMid:9990849   Deveraux QL, Leo E, Stennicke HR, Welsh K, et al. (1999). Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 18: 5242-5251. PMid:10508158 PMCid:1171595   Fu WN, Bertoni F, Kelsey SM, McElwaine SM, et al. (2003). Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene 22: 451-455. PMid:12545166   Furukawa Y, Sutheesophon K, Wada T, Nishimura M, et al. (2005). Methylation silencing of the Apaf-1 gene in acute leukemia. Mol. Cancer Res. 3: 325-334. PMid:15972851   Hanahan D and Weinberg RA (2000). The hallmarks of cancer. Cell 100: 57-70.   Hinz S, Kempkensteffen C, Weikert S, Schostak M, et al. (2007). EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder. Tumour. Biol. 28: 151-157. PMid:17541304   Jia L, Srinivasula SM, Liu FT, Newland AC, et al. (2001). Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood 98: 414-421. PMid:11435311   King ED, Matteson J, Jacobs SC and Kyprianou N (1996). Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J. Urol. 155: 316-320.   Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD (1997). The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136. PMid:9027315   Li K, Li Y, Shelton JM, Richardson JA, et al. (2000). Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 101: 389-399.   Li M, Song T, Yin ZF and Na YQ (2007). XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer. Chin. Med. J. 120: 469-473.   Li P, Nijhawan D, Budihardjo I, Srinivasula SM, et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489.   Liu X, Kim CN, Yang J, Jemmerson R, et al. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.   Nakanishi K, Tominaga S, Kawai T, Torikata C, et al. (1998). Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract. Virchows Arch. 432: 445-450. PMid:9645444   Newmeyer DD, Farschon DM and Reed JC (1994). Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79: 353-364.   Ohl F, Jung M, Radonic A, Sachs M, et al. (2006). Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer. J. Urol. 175: 1915-1920.   Ow YP, Green DR, Hao Z and Mak TW (2008). Cytochrome c: functions beyond respiration. Nat. Rev. Mol. Cell Biol. 9: 532-542. PMid:18568041   Parkin DM, Bray F, Ferlay J and Pisani P (2001a). Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94: 153-156. PMid:11668491   Parkin DM, Bray FI and Devesa SS (2001b). Cancer burden in the year 2000. The global picture. Eur. J. Cancer 37 (Suppl 8): S4-66.   Parton M, Krajewski S, Smith I, Krajewska M, et al. (2002). Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin. Cancer Res. 8: 2100-2108. PMid:12114409   Pashos CL, Botteman MF, Laskin BL and Redaelli A (2002). Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract. 10: 311-322. PMid:12406054   Raff M (1998). Cell suicide for beginners. Nature 396: 119-122. PMid:9823889   Reed JC, Miyashita T, Takayama S, Wang HG, et al. (1996). BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell Biochem. 60: 23-32.<23::AID-JCB5>3.0.CO;2-5   Riedl SJ and Shi Y (2004). Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5: 897-907. PMid:15520809   Salvesen GS and Duckett CS (2002). IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3: 401-410. PMid:12042762   Shi Y (2002). Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9: 459-470.   Shiina H, Igawa M, Urakami S, Honda S, et al. (1996). Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder. J. Clin. Pathol. 49: 395-399. PMid:8707954 PMCid:500479   Soengas MS, Capodieci P, Polsky D, Mora J, et al. (2001). Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409: 207-211. PMid:11196646   Strasser A, Harris AW, Bath ML and Cory S (1990). Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331-333. PMid:2250704   Takeuchi H, Kim J, Fujimoto A, Umetani N, et al. (2005). X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling. Clin. Cancer Res. 11: 7621-7628. PMid:16278380   Zhivotovsky B, Orrenius S, Brustugun OT and Doskeland SO (1998). Injected cytochrome c induces apoptosis. Nature 391: 449-450. PMid:9461210   Zou H, Henzel WJ, Liu X, Lutschg A, et al. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413.